{
 "as_of": "2026-11-11",
 "cmr": "nl-cm-kg/XAMS/NL00150002Q7",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# VIVORYON THERAPEUTICS N.V. (Euronext Amsterdam: NL00150002Q7) — research page\n\nAs of 2026-11-11 · nl-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is VIVORYON THERAPEUTICS N.V., listed on Euronext Amsterdam under ticker NL00150002Q7, with ISIN NL00150002Q7 and LEI 3912004AMB0KGZXZYJ15. Its security type is Corporate and its jurisdiction is Netherlands (KVK-registered). The segment is not on the record, and the sector is not on the record, as there is no sector on the FIRDS record and no machine-readable register activity code. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 42 filings in the window from 2025-11-11 to 2026-11-11, across 26 filing days. The median gap between filing days is 9 days. The latest filing is dated 2026-11-07 and is of type results, 4 days before the record date of 2026-11-11. The exchange median cadence gap is 10.2 days across 123 issuers, the median filings count is 15, and the median latency is 7.0 days. The issuer's 42 filings are above the exchange median of 15 filings. The sector peer comparison is not on the record for this market. Filings by type are: 17 results, 15 newswire releases, 5 directors' dealings, 3 ad hoc, and 2 AGM/EGM.\n\n## Auditor\n\nThe auditor of record is not on the record. The record carries the annual report link only, as a source link and not a read. The auditor's location and any auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is clear: the issuer is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category under the rule version acm-68000/nl/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's own investor-relations page, count 0.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe vintage of this market is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)\n- https://api.gleif.org/api/v1/lei-records/3912004AMB0KGZXZYJ15 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.nl-cm-kg.ai/events/XAMS/NL00150002Q7 (the disclosure lines)\n- https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)\n- https://mcp.nl-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.nl-cm-kg.ai/record/XAMS/NL00150002Q7 (the record)\n",
 "market": "NL",
 "node": "nl-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the NL vintage is not sealed; the record is the live record as of 2026-11-11",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "NL",
    "reason": "Width 0 records the annual report link only (ORDER-016: source link, not a read)",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "NL",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "NL",
    "state": "not_on_record"
   },
   "changes": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "nl-cm-kg/XAMS/NL00150002Q7",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [
    {
     "page": "https://www.vivoryon.com/stock-information/",
     "result": "read: 3 of 3 named houses found on the page; the page does not name the issuer"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 123,
     "median_cadence_gap_days": 10.2,
     "median_filings": 15,
     "median_latency_days": 7,
     "name": "Euronext Amsterdam"
    },
    "sector": {
     "market": "NL",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "ad_hoc": 3,
    "agm_egm": 2,
    "directors_dealings": 5,
    "newswire_release": 15,
    "results": 17
   },
   "cadence_median_gap_days": 9,
   "filing_days": 26,
   "filings": 42,
   "latency_days": 4,
   "latest": [
    {
     "category": null,
     "date": "2026-11-07",
     "source": "https://www.globenewswire.com/news-archive/3279553/11666/en/vivoryon-therapeutics-n-v-reports-full-year-2025-financial-results-and-provides-business-update.html/timezone/Romance%20Standard%20Time?dateformat=dd+MMMM+yyyy",
     "title": "Vivoryon Therapeutics N.V. Reports Full Year 2025 ...",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-11-05",
     "source": "https://www.globenewswire.com/news-release/2026/11/05/3396030/0/en/vivoryon-therapeutics-n-v-reports-q3-2026-financial-results-and-provides-business-update.html",
     "title": "Vivoryon Therapeutics N.V. Reports Q3 2026 Financial",
     "type": "newswire_release"
    },
    {
     "category": "inside information",
     "date": "2026-11-05",
     "source": "https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2611-00289",
     "title": "Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update",
     "type": "results"
    },
    {
     "category": "inside information",
     "date": "2026-11-05",
     "source": "https://www.afm.nl/en/sector/registers/meldingenregisters/openbaarmaking-voorwetenschap/details?id=C2609-00903",
     "title": "Vivoryon Therapeutics N.V. Reports Q3 2026 Financial Results and Provides Business Update",
     "type": "results"
    },
    {
     "category": null,
     "date": "2026-11-04",
     "source": "https://www.globenewswire.com/news-archive/3392040/11666/en/vivoryon-therapeutics-n-v-to-report-q3-2026-financial-results-on-november-5-2026.html/timezone/Romance%20Standard%20Time",
     "title": "Vivoryon Therapeutics N.V. to Report Q3 2026 Financial ...",
     "type": "newswire_release"
    }
   ],
   "latest_filing_date": "2026-11-07",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.nl-cm-kg.ai/events/XAMS/NL00150002Q7",
   "window": {
    "from": "2025-11-11",
    "to": "2026-11-11"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Euronext Amsterdam"
   },
   "isin": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "confirmed",
    "value": "NL00150002Q7"
   },
   "jurisdiction": {
    "read_by": "GLEIF LEI record (LEI per the LEI column) (registeredAt KVK)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://api.gleif.org/api/v1/lei-records/3912004AMB0KGZXZYJ15",
    "state": "sourced",
    "value": "Netherlands (KVK-registered)"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-12",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN NL00150002Q7)",
    "state": "sourced",
    "value": "3912004AMB0KGZXZYJ15"
   },
   "name": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "VIVORYON THERAPEUTICS N.V."
   },
   "sector": {
    "market": "NL",
    "reason": "no sector on the FIRDS record and no machine-readable register activity code",
    "state": "not_on_record"
   },
   "security_type": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "NL",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "ESMA FIRDS full equity file (EU instrument reference data per trading venue)",
    "read_date": "2026-11-11",
    "read_date_basis": "the record version as_of",
    "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (FIRDS full equity files 2026-09-05)",
    "state": "sourced",
    "value": "NL00150002Q7"
   },
   "website": {
    "market": "NL",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "NL",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "NL",
  "node": "nl-cm-kg",
  "numbers_hash": "sha256:7897318f2126e6e589bed4f28712ff067388237aeef2098f3874f5b120917dc0",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.nl-cm-kg.ai/book/aio.json",
    "door": "https://mcp.nl-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/nl/mifid-ii-product-governance/r1",
   "section": "nl.aio.v11"
  },
  "record": {
   "as_of": "2026-11-11",
   "url": "https://mcp.nl-cm-kg.ai/record/XAMS/NL00150002Q7",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-12",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:7897318f2126e6e589bed4f28712ff067388237aeef2098f3874f5b120917dc0",
 "path": "/nl/XAMS/NL00150002Q7",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is VIVORYON THERAPEUTICS N.V., listed on Euronext Amsterdam under ticker NL00150002Q7, with ISIN NL00150002Q7 and LEI 3912004AMB0KGZXZYJ15. Its security type is Corporate and its jurisdiction is Netherlands (KVK-registered). The segment is not on the record, and the sector is not on the record, as there is no sector on the FIRDS record and no machine-readable register activity code. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 42 filings in the window from 2025-11-11 to 2026-11-11, across 26 filing days. The median gap between filing days is 9 days. The latest filing is dated 2026-11-07 and is of type results, 4 days before the record date of 2026-11-11. The exchange median cadence gap is 10.2 days across 123 issuers, the median filings count is 15, and the median latency is 7.0 days. The issuer's 42 filings are above the exchange median of 15 filings. The sector peer comparison is not on the record for this market. Filings by type are: 17 results, 15 newswire releases, 5 directors' dealings, 3 ad hoc, and 2 AGM/EGM.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record. The record carries the annual report link only, as a source link and not a read. The auditor's location and any auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is clear: the issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category under the rule version acm-68000/nl/mifid-ii-product-governance/r1, with the chapter as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's own investor-relations page, count 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The vintage of this market is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://api.gleif.org/api/v1/lei-records/3912004AMB0KGZXZYJ15"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.nl-cm-kg.ai/events/XAMS/NL00150002Q7"
  },
  {
   "for": "the halt flag",
   "source": "https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.nl-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.nl-cm-kg.ai/record/XAMS/NL00150002Q7"
  }
 ],
 "title": "VIVORYON THERAPEUTICS N.V. (NL00150002Q7) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}